CVE-2025-2230
Philips Intellispace Cardiovascular (ISCV) Improper Authentication
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
8.5
Philips Intellispace Cardiovascular (ISCV) Improper Authentication
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.
- Record
CVE-2025-2230- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-287
- Updated
- 2026-11-02
EUVDEUVD-2025-6388
8.5
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.
- Record
EUVD-2025-6388- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-m4v2-r3w8-c73j
8.5
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay...
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.
- Record
GHSA-m4v2-r3w8-c73j- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-287
- Updated
- 2026-11-02
NVD
8.5
A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.
- Record
CVE-2025-2230- CVSS 4.0
- 8.5 High
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 7.7 High
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N - Weakness
- CWE-287
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2025-2230 is a high vulnerability (CVSS 8.5) in Philips Intellispace Cardiovascular (iscv), published March 13, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.24%, the 14th percentile. No source names a fixed version.